NetTargets and Cellkey sign MoU to collaborate on biomarker discovery

NetTargets Inc.

09 Jun 2021

NetTargets has partnered with Cellkey, which provides a cutting-edge AI-based glycopeptide analysis platform, to discover biomarkers for early detection and treatment of cancer.

NetTargets and Daewoong Therapeutics signed MoU on anticancer drug research collaboration

NetTargets has partnered with Daewoong Therapeutics, for an anticancer drug research collaboration using NetTargets N-Map and N-Cap which are "AI-enhanced systems biology" based drug development platforms.

NetTargets Inc. is introduced as one of the rising AI startup

The Korea Economic Daily introduced NetTargets Inc. as a rising AI startup, featuring its technology as the golden-egg goose.

NetTargets Inc. is selected for the Korea AI Startup 100

Korea AI Startup 100 is a project to discover next-generation unicorn companies in the field of artificial intelligence (AI).

Comming soon

Our next news and events are coming soon

Comming soon

Our next news and events are coming soon

Comming soon

Our next news and events are coming soon

BACK TO THE LIST

SITEMAP

CONTACT US